Cargando…

Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart

PURPOSE: The incidence of single positive core prostate cancer at the time of biopsy appears to be increasing in the prostate-specific antigen (PSA) era. To determine the clinical implication of this disease, we analyzed surgical and pathological characteristics in comparison with multiple positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Hong Jae, Ko, Young Hwii, Jang, Hoon Ah, Kang, Sung Gu, Kang, Seok Ho, Park, Hong Seok, Lee, Jeong Gu, Kim, Je Jong, Cheon, Jun
Formato: Texto
Lenguaje:English
Publicado: The Korean Urological Association 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963778/
https://www.ncbi.nlm.nih.gov/pubmed/21031085
http://dx.doi.org/10.4111/kju.2010.51.10.671
_version_ 1782189309949902848
author Ahn, Hong Jae
Ko, Young Hwii
Jang, Hoon Ah
Kang, Sung Gu
Kang, Seok Ho
Park, Hong Seok
Lee, Jeong Gu
Kim, Je Jong
Cheon, Jun
author_facet Ahn, Hong Jae
Ko, Young Hwii
Jang, Hoon Ah
Kang, Sung Gu
Kang, Seok Ho
Park, Hong Seok
Lee, Jeong Gu
Kim, Je Jong
Cheon, Jun
author_sort Ahn, Hong Jae
collection PubMed
description PURPOSE: The incidence of single positive core prostate cancer at the time of biopsy appears to be increasing in the prostate-specific antigen (PSA) era. To determine the clinical implication of this disease, we analyzed surgical and pathological characteristics in comparison with multiple positive core disease. MATERIALS AND METHODS: Among 108 consecutive patients who underwent robotic radical prostatectomy following a diagnosis of prostate cancer based on a 12-core transrectal biopsy performed by the same method in a single institute, outcomes from 26 patients (Group 1) diagnosed on the basis of a single positive biopsy core and from 82 patients (Group 2) with multiple positive biopsy cores were analyzed. RESULTS: The preoperative PSA value, Gleason score, prostate volume, and D'Amico's risk classification of each group were similar. The proportion of intermediate+highrisk patients was 69.2% in Group 1 and 77.9% in Group 2 (p=0.22). Total operative time and blood loss were similar. Based on prostatectomy specimens, only 3 patients (11.5%) in Group 1 met the criteria for an indolent tumor (7.31% in Group 2). Although similarities were observed during preoperative clinical staging (p=0.13), the final pathologic stage was significantly higher in Group 2 (p=0.001). The positive-margin rate was also higher in Group 2 (11.5% vs. 31.7%, p=0.043). Despite similarity in upstaging after prostatectomy in each group (p=0.86), upgrading occurred more frequently in Group 1 (p=0.014, 42.5% vs. 19.5%). No clinical parameters were valuable in predicting upgrading. CONCLUSIONS: Most single positive core prostate cancer diagnoses in 12-core biopsy were clinically significant with similar risk stratification to multiple positive core prostate cancers. Although the positive-margin rate was lower than in multiple positive core disease, an increase in Gleason score after radical prostatectomy occurred more frequently.
format Text
id pubmed-2963778
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The Korean Urological Association
record_format MEDLINE/PubMed
spelling pubmed-29637782010-10-28 Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart Ahn, Hong Jae Ko, Young Hwii Jang, Hoon Ah Kang, Sung Gu Kang, Seok Ho Park, Hong Seok Lee, Jeong Gu Kim, Je Jong Cheon, Jun Korean J Urol Original Article PURPOSE: The incidence of single positive core prostate cancer at the time of biopsy appears to be increasing in the prostate-specific antigen (PSA) era. To determine the clinical implication of this disease, we analyzed surgical and pathological characteristics in comparison with multiple positive core disease. MATERIALS AND METHODS: Among 108 consecutive patients who underwent robotic radical prostatectomy following a diagnosis of prostate cancer based on a 12-core transrectal biopsy performed by the same method in a single institute, outcomes from 26 patients (Group 1) diagnosed on the basis of a single positive biopsy core and from 82 patients (Group 2) with multiple positive biopsy cores were analyzed. RESULTS: The preoperative PSA value, Gleason score, prostate volume, and D'Amico's risk classification of each group were similar. The proportion of intermediate+highrisk patients was 69.2% in Group 1 and 77.9% in Group 2 (p=0.22). Total operative time and blood loss were similar. Based on prostatectomy specimens, only 3 patients (11.5%) in Group 1 met the criteria for an indolent tumor (7.31% in Group 2). Although similarities were observed during preoperative clinical staging (p=0.13), the final pathologic stage was significantly higher in Group 2 (p=0.001). The positive-margin rate was also higher in Group 2 (11.5% vs. 31.7%, p=0.043). Despite similarity in upstaging after prostatectomy in each group (p=0.86), upgrading occurred more frequently in Group 1 (p=0.014, 42.5% vs. 19.5%). No clinical parameters were valuable in predicting upgrading. CONCLUSIONS: Most single positive core prostate cancer diagnoses in 12-core biopsy were clinically significant with similar risk stratification to multiple positive core prostate cancers. Although the positive-margin rate was lower than in multiple positive core disease, an increase in Gleason score after radical prostatectomy occurred more frequently. The Korean Urological Association 2010-10 2010-10-21 /pmc/articles/PMC2963778/ /pubmed/21031085 http://dx.doi.org/10.4111/kju.2010.51.10.671 Text en Copyright © The Korean Urological Association, 2010 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ahn, Hong Jae
Ko, Young Hwii
Jang, Hoon Ah
Kang, Sung Gu
Kang, Seok Ho
Park, Hong Seok
Lee, Jeong Gu
Kim, Je Jong
Cheon, Jun
Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart
title Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart
title_full Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart
title_fullStr Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart
title_full_unstemmed Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart
title_short Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart
title_sort single positive core prostate cancer in a 12-core transrectal biopsy scheme: clinicopathological implications compared with multifocal counterpart
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963778/
https://www.ncbi.nlm.nih.gov/pubmed/21031085
http://dx.doi.org/10.4111/kju.2010.51.10.671
work_keys_str_mv AT ahnhongjae singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart
AT koyounghwii singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart
AT janghoonah singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart
AT kangsunggu singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart
AT kangseokho singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart
AT parkhongseok singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart
AT leejeonggu singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart
AT kimjejong singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart
AT cheonjun singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart